SCHEMBL10046165

SCHEMBL10046165

Brc1cc(OCc2ccccc2)cc(OCc2ccccc2)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 12/20 0.72
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
ALOX5 P09917 1/20 0.55
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
PTGS1 P23219 1/20 0.53
SLC6A2 P23975 1/20 0.53
CYP2C19 P33261 1/20 0.53
PTGS2 P35354 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HIF1A Q16665 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
MAOA P21397 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MRGPRX4 Q96LA9 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL308991 0.96 MAOB (0.72) MAOBMEN1KMT2AALOX5LMNA
SCHEMBL7743406 0.91 MAOB (0.67) MAOBMEN1KMT2AALOX5
SCHEMBL4674930 0.89 MEN1 (0.70) MAOBMEN1KMT2AALOX5LMNA
SCHEMBL31418062 0.89 MAOB (0.64) MAOBMEN1KMT2AALOX5LMNA
SCHEMBL347904 0.87 MAOB (0.62) MAOBMEN1KMT2AALOX5LMNA
SCHEMBL2150956 0.87 MAOB (0.62) MAOBMEN1KMT2AALOX5LMNA
SCHEMBL4073348 0.87 MAOB (0.62) MAOBMEN1KMT2AALOX5LMNA
SCHEMBL2226602 0.87 MAOB (0.62) MAOBMEN1KMT2AALOX5LMNA
SCHEMBL221836 0.87 MAOB (0.62) MAOBMEN1KMT2AALOX5LMNA
SCHEMBL22489859 0.87 MAOB (0.63) MAOBMEN1KMT2AALOX5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2024-07-04 US disclosed
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2024-07-04 US disclosed
US-20230067037-A1 CONJUGATED CHEMICAL INDUCERS OF DEGRADATION AND METHODS OF USE GENENTECH, INC. (US) 2023-03-02 US disclosed
WO-2019040792-A1 SECOND GENERATION GRP94-SELECTIVE INHIBITORS UNIVERSITY OF KANSAS (US) 2019-02-28 WO disclosed
EP-2744778-B1 META-SUBSTITUTED BIPHENYL PERIPHERALLY RESTRICTED FAAH INHIBITORS UNIV CALIFORNIA (US) 2019-01-16 EP disclosed
EP-2818531-B1 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2017-07-26 EP disclosed
EP-2818531-B1 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2017-07-26 EP disclosed
US-9567526-B2 Polymerizable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2017-02-14 US disclosed
EP-2605767-B1 SHIP1 MODULATORS AND RELATED METHODS UNIV BRITISH COLUMBIA (CA) 2016-07-27 EP disclosed
EP-2605767-B1 SHIP1 MODULATORS AND RELATED METHODS UNIV BRITISH COLUMBIA (CA) 2016-07-27 EP disclosed
US-9000050-B2 SHIP1 modulators and related methods THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2015-04-07 US disclosed
US-9000050-B2 SHIP1 modulators and related methods THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2015-04-07 US disclosed
EP-2818531-A1 Polymerisable compounds and the use thereof in liquid-crystal displays Merck Patent GmbH (DE) 2014-12-31 EP disclosed
US-20140375943-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2014-12-25 US disclosed
EP-2744778-A2 META-SUBSTITUTED BIPHENYL PERIPHERALLY RESTRICTED FAAH INHIBITORS The Regents of the University of California (US) 2014-06-25 EP disclosed
US-20130217674-A1 SHIP1 MODULATORS AND RELATED METHODS THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-08-22 US disclosed
US-20130217674-A1 SHIP1 MODULATORS AND RELATED METHODS THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-08-22 US disclosed
US-20130217674-A1 SHIP1 MODULATORS AND RELATED METHODS THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-08-22 US disclosed
WO-2013028570-A2 META-SUBSTITUTED BIPHENYL PERIPHERALLY RESTRICTED FAAH INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-02-28 WO disclosed
WO-2012024682-A1 SHIP1 MODULATORS AND RELATED METHODS THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2012-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230067037-A1 CONJUGATED CHEMICAL INDUCERS OF DEGRADATION AND METHODS OF USE ADRM1, SSB, FCER2 MAOB 3032/4885MEN1 4419/4885KMT2A 4147/4885
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF KDM1A, TET1, KDM3A MAOB 431/4885MEN1 1113/4885KMT2A 43/4885
US-20130217674-A1 SHIP1 MODULATORS AND RELATED METHODS PPM1D, PPP1R1B, PPM1G MAOB 4360/4885MEN1 1626/4885KMT2A 3805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.